Standard BioTools Inc. (LAB) company profile

Standard BioTools Inc. provides life science tools and technologies designed to assist biomedical researchers in developing therapeutics. The company offers a portfolio of instrumentation, consumables, and laboratory services supporting multi-omic research across proteomics and genomics. Its core commercial platforms include CyTOF for single-cell mass cytometry, Hyperion for spatial biology and imaging mass cytometry, and Biomark for genomic analyses. These products enable scientists to analyze cellular functions, map tissue architectures, and explore disease mechanisms in areas such as oncology, immunology, and neurology.

The company operates internationally, serving customers across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with specific geographic exposure in countries such as the United States, Canada, China, Sweden, and Singapore. Standard BioTools maintains its principal executive offices in Boston, Massachusetts.

Summary of the business section of Standard BioTools's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025, we had a total of 389 employees worldwide, excluding employees associated with our discontinued operations, of which 385 were full-time employees and 96 were located in the United States.”